Management of PCOS in Menopause

Metabolic and Cardiovascular Risk Management

The American College of Physicians recommends screening all postmenopausal women with PCOS for type 2 diabetes using fasting glucose followed by a 2-hour glucose level after a 75-gram oral glucose load, repeating annually or every 1-2 years based on BMI and family history 1, 2
Obtain comprehensive fasting lipid profile including total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides at baseline and monitor regularly, as recommended by the American Heart Association 1, 2
Calculate BMI and waist-hip ratio at each visit, using ethnic-specific cutoffs for high-risk populations, as suggested by the American Diabetes Association 1, 3
Implement multicomponent lifestyle intervention targeting at least 150 minutes/week of moderate-intensity physical activity or 75 minutes/week of vigorous-intensity activity, plus muscle-strengthening activities on 2 non-consecutive days per week, as recommended by the American College of Sports Medicine 3, 4
Prescribe a balanced diet creating a 500-750 kcal/day energy deficit if weight loss is needed, emphasizing low glycemic index foods, high fiber, omega-3 fatty acids, and anti-inflammatory dietary patterns, as suggested by the Academy of Nutrition and Dietetics 3, 4
Weight loss of even 5% improves metabolic parameters, though cardiovascular risk reduction is the priority regardless of weight achieved, according to the American Heart Association 5, 3

Prescribe metformin (500-2000 mg daily) for women with documented insulin resistance, glucose intolerance, or established type 2 diabetes to reduce cardiovascular and metabolic risk, as recommended by the American Diabetes Association 1, 2
Consider newer anti-obesity agents (GLP-1 receptor agonists such as semaglutide or liraglutide) for weight management when lifestyle interventions alone are insufficient, as suggested by the Endocrine Society 3, 4

For persistent bothersome hirsutism, use antiandrogen therapy with spironolactone (50-200 mg daily) or finasteride, combined with mechanical hair removal methods, as recommended by the American Academy of Dermatology 1, 5
Topical eflornithine hydrochloride cream is FDA-approved for hirsutism and can be used adjunctively, according to the FDA 1, 5

Standard menopausal hormone therapy (HRT) guidelines apply to women with PCOS—transdermal 17-β estradiol is preferred over oral formulations to minimize thrombotic risk, as recommended by the North American Menopause Society 6
HRT should be considered for vasomotor symptoms and bone protection, continuing until at least the average age of natural menopause, according to the American College of Obstetricians and Gynecologists 6

Screen for depression, anxiety, and body image concerns, as PCOS has significant negative impact on psychological wellbeing that persists into menopause, as recommended by the American Psychological Association 6, 3
Ensure psychological and lifestyle interventions are accessible, with patient-centered, respectful interactions that avoid weight-related stigma, as suggested by the National Eating Disorders Association 6, 4